There are 133 papers on LDL in aging research: 24 trials and 58 observational studies in people, 15 in animals, 1 in cells, 33 reviews.
133 papers study it27 findings
23 new papers in 30 daysSee all 133 papers on LDL
“In the experimental arm, changes in LDL levels were positively correlated with HOMA-IR and insulin levels, and inversely correlated with QUICKI.”
- Human trial24
- Humans58
- Animals15
- Cells1
- In silico1
Interventions
9Oligo-fucoidan + fucoxanthin + L-carnitine
downin humans1
1 study
Oligo-fucoidan + fucoxanthin + L-carnitine
downin humans1
Oligo-fucoidan + fucoxanthin + L-carnitine decreases LDL in humans (DKD patients receiving adjunctive FFL) (GMR 0.85 (95% CI 0.76–0.95); maximum 24.28% reduction in patients with baseline dyslipidemia).
“FFL also significantly lowered baseline-adjusted LDL (GMR = 0.85; 95% CI: 0.76-0.95; p < 0.01)”
Human trialDKD patients receiving adjunctive FFLstandardized marine formula12 weeks
Phytomedicine : international journal of phytotherapy and phytopharmacology
Cinaciguat
downin rats1
1 study
Cinaciguat
downin rats1
Cinaciguat decreases LDL in rats.
“Surprisingly, cinaciguat also reversed age-related increases in LDL”
Animalstwo weeks
Activating soluble guanylate cyclase restores amyloid-beta and LDL clearance in aged rats
The Journal of biological chemistry
Pitavastatin + ezetimibe
downin humans1
1 study
Pitavastatin + ezetimibe
downin humans1
Pitavastatin + ezetimibe decreases LDL in humans (network meta-analysis of LDL reduction).
“For LDL reduction, the combination of moderate-intensity pitavastatin and ezetimibe was the most effective”
Reviewnetwork meta-analysis of LDL reductionmoderate-intensityn = 43,625
Journal of geriatric cardiology : JGC
Acupuncture and moxibustion
downin humans1
1 study
Acupuncture and moxibustion
downin humans1
Acupuncture and moxibustion decreases LDL in individuals with initially abnormal LDL and UA values (4.46 mmol/L to 3.97 mmol/L (P = 0.004)).
“For 6 months acupuncture and moxibustion at ST36 significantly reduced levels of low-density lipoprotein (LDL) and uric acid (UA) in individuals with initially abnormal LDL and UA values.”
Human trialin individuals with initially abnormal LDL and UA values6 monthsn = 48
Frontiers of medicine
Combination therapy
downin humans1
1 study
Combination therapy
downin humans1
Combination therapy decreases LDL in humans (synergistic use with non-statin lipid-lowering agents) (< 40 mg/dL).
“early adoption of combination therapies allow previously theoretical LDL targets (< 40 mg/dL) to be achieved through the synergistic use of non-statin lipid-lowering agents”
Reviewsynergistic use with non-statin lipid-lowering agents
Internal and emergency medicine
Statins
downin humans1
1 study
Statins
downin humans1
Statins are linked with lower LDL in humans after coronary revascularization (PCI or CABG) (median 61 mg/dL).
“achieved post-revascularization LDL levels of 61mg/dL and 67 mg/dL in males and females, respectively”
Humansafter coronary revascularization (PCI or CABG)males
Yentl Syndrome Refuted: Cholesterol Management from a Multicenter Healthcare System
AHA Scientific Sessions 2025 abstract
Foot reflexology
no changein humans1
1 study
Foot reflexology
no changein humans1
Foot reflexology showed no clear effect on LDL in humans (MD -0.55).
“However, the LDL (MD=-0.55), DBP (MD=-1.65) reduction, and FFM (MD=-2.24) maintenance did not differ between groups (p > 0.05).”
Human trial14 weeksfemalesn = 40
Journal of diabetes and metabolic disorders
Time-restricted feeding
upin humans1
1 study
Time-restricted feeding
upin humans1
Time-restricted feeding increases LDL in adults with overweight and obese (MD = 2.70, 95% CI 0.17-5.22).
“increased low-density lipoprotein (LDL) (MDpooled = 2.70, 95% CI = 0.17~5.22, p = 0.037)”
Reviewin adults with overweight and obesen = 1,288
Nutrients
High-intensity interval training
downin humans1
1 study
High-intensity interval training
downin humans1
High-intensity interval training decreases LDL in humans (nondiabetic overweight and obese young adults) (-12.14 mg/dL, p < 0.00001).
“Compared to CON, HIIT significantly decreased the concentrations of LDL (-12.14 mg/dL, p = < 0.00001)”
Reviewnondiabetic overweight and obese young adults
International journal of exercise science
Effects
3White matter integrity
upin humans1downin humans1
1 study
White matter integrity
upin humans1downin humans1
LDL is linked with higher white matter integrity in non-carriers (b= 0.05, CI= [0.04, 0.07]).
“whereas an increase (b= 0.05, CI= [0.04, 0.07]) among non-carriers”
Humansin non-carriers
APOE4 poses opposite effects of plasma LDL on white matter integrity in older adults
bioRxiv : the preprint server for biologyPreprint
LDL is linked with lower white matter integrity in older APOE4 carriers (b= -0.12, CI= [-0.14, -0.10]).
“The increase in the concentration of metabolites, mainly LDL and VLDL, is associated with a decrease in white matter integrity (b= -0.12, CI= [-0.14, -0.10]) among older APOE4 carriers”
Humansin older APOE4 carriers
APOE4 poses opposite effects of plasma LDL on white matter integrity in older adults
bioRxiv : the preprint server for biologyPreprint
White matter hyperintensity volume
no changein humans1
1 study
White matter hyperintensity volume
no changein humans1
LDL was not clearly linked with white matter hyperintensity volume in humans.
“No significant differences in WMH volume were observed between LDL categories or triglyceride categories.”
Humanswhite mattern = 170
AAIC 2025 abstract
Coronary artery disease
no changein humans1HR 1.05
1 study
Coronary artery disease
no changein humans1HR 1.05
LDL was not clearly linked with coronary artery disease in patients who developed incident DM after statin prescription (HR 1.05 per 50 mg/dL, 95% CI 0.85–1.28).
“baseline LDL was not a significant predictor of incident CAD (HR 1.05 per 50 mg/dL, 95% CI 0.85–1.28, P=0.649)”
Humansin patients who developed incident DM after statin prescription
Assessing Cardiovascular Risk in Patients with New Onset Diabetes After Statin Initiation
AHA Scientific Sessions 2025 abstract
Upstream
2Obesity
no changein humans1
1 study
Obesity
no changein humans1
Obesity was not clearly linked with LDL in Australian adults.
“total LDL concentration was similar between the BMI categories”
Humansin Australian adults
International journal of obesity (2005)
CETP
no changein humans1
1 study
CETP
no changein humans1
CETP was not clearly linked with LDL in humans (CETP V405V genotype) (P = 0.62 and P = 0.18, respectively).
“whereas LDL and triglyceride levels were unchanged (P = 0.62 and P = 0.18, respectively).”
HumansCETP V405V genotype
BMC geriatrics
Associations
11HOMA-IR
upin humans1
1 study
HOMA-IR
upin humans1
LDL is associated with HOMA-IR in humans (changes within the experimental arm of patients with MASLD).
“In the experimental arm, changes in LDL levels were positively correlated with HOMA-IR and insulin levels, and inversely correlated with QUICKI.”
Human trialchanges within the experimental arm of patients with MASLDwhole “Navelina” oranges400 g/day4 weeks
Nutrients
P210 IgG
downin humans1
1 study
P210 IgG
downin humans1
P210 IgG is associated with LDL in humans (CACS>0).
“P210 IgG levels were lower in subjects with CACS>0 and inversely correlated with LDL among subjects with CACS>0.”
HumansCACS>0
Proteomic and Autoantibody Signatures Link Coronary Plaque with ApoB-Related Immune Dysregulation
AHA Scientific Sessions 2026 abstract
Nutrition Knowledge Scale score
downin humans1
1 study
Nutrition Knowledge Scale score
downin humans1
Nutrition Knowledge Scale score is associated with LDL in humans (fitness center members; adjusted for BMI and gender) (β = -0.136, p = 0.037).
“The total "Nutrition Knowledge Scale" score was significantly associated with LDL levels after adjustment for BMI and gender (β = -0.136, p = 0.037)”
Humansfitness center members; adjusted for BMI and gendern = 230
Metabolites
Low muscle high fat phenotype
upin humans1
1 study
Low muscle high fat phenotype
upin humans1
Low muscle high fat phenotype is associated with LDL in normal-weight Asian Indians (P=0.01).
“Both LDL and TG were significantly higher in the LMHF phenotype (P=0.01).”
Humansin normal-weight Asian Indians
Clinical Nutrition Open Science
Genetic liability to type 2 diabetes
upin humans1
1 study
Genetic liability to type 2 diabetes
upin humans1
Genetic liability to type 2 diabetes is associated with LDL in humans (genetically predicted liability to T2D).
“more modestly positively associated with intermediate-density lipoprotein and LDL, particularly small LDL, particles”
Humansgenetically predicted liability to T2D
Diabetes care
Estimated pulse wave velocity
upin humans1
1 study
Estimated pulse wave velocity
upin humans1
Estimated pulse wave velocity is associated with LDL in humans (Treated hypertension; adjusted for age, age squared, and 24-hour systolic blood pressure) (r = 0.359, p = 0.004).
“positively correlated only with total cholesterol (r = 0.243, p = 0.043) and LDL (r = 0.359, p = 0.004).”
HumansTreated hypertension; adjusted for age, age squared, and 24-hour systolic blood pressure24 hoursn = 131
International journal of hypertension
Rest-activity rhythms
upin humans1
1 study
Rest-activity rhythms
upin humans1
Rest-activity rhythms are associated with LDL in humans (β = 87.94, p = 0.023).
“LDL (β = 87.94, p = 0.023), but not with IL-6 and C-Reactive Protein”
Humansn = 440
Sex as a Moderator in the Association Between Rest-Activity Rhythms and Cardiometabolic Profiles
GSA 2025 abstract
Coronary artery disease
downin humans1HR 0.78
1 study
Coronary artery disease
downin humans1HR 0.78
LDL is linked with a lower risk of coronary artery disease in humans among patients without incident DM (HR 0.78 per 50 mg/dL increase, 95% CI 0.75–0.82).
“baseline LDL was protective (HR 0.78 per 50 mg/dL increase, 95% CI 0.75–0.82, P<0.001)”
Humansamong patients without incident DM
Assessing Cardiovascular Risk in Patients with New Onset Diabetes After Statin Initiation
AHA Scientific Sessions 2025 abstract
Alzheimer's disease
upin reviews1
1 study
Alzheimer's disease
upin reviews1
LDL is associated with Alzheimer's disease (elevated plasma LDL).
“Recent studies show an association between elevated plasma LDL, a well-known cardiovascular risk factor, and a higher risk of AD”
Reviewelevated plasma LDL
Molecular neurodegeneration
Incident dementia
downin humans1HR 0.918
1 study
Incident dementia
downin humans1HR 0.918
LDL is associated with incident dementia in humans (HR 0.918, 95% CI 0.872–0.965).
“lipids dysregulation: lower LDL (HR 0.918, 95% CI: 0.872-0.965)”
HumansserumMedian follow-up of 9.19 yearsn = 407,190
Translational psychiatry
All 11Fewer
Funding
4 grants since 2018National Heart, Lung, and Blood Institute$2.6MUS Department of Veterans AffairsAmerican Heart Association
Molecular Regulation of LDL Receptor Expression
National Heart, Lung, and Blood InstituteUniversity of Michigan at Ann Arbor$607K2024–2028
American Heart Association2026–2027
MicroRNAs regulating plasma LDL and HDL
US Department of Veterans AffairsVa New York Harbor Hlthcare/sys/brooklyn2018–2023
B cell anergy, modified LDL uptake, and atherosclerosis
National Heart, Lung, and Blood InstituteEastern Virginia Medical School$484K2018–2024